tradingkey.logo

Alpha Teknova Inc

TKNO
4.710USD
-0.100-2.08%
收盤 11/07, 16:00美東報價延遲15分鐘
252.05M總市值
虧損本益比TTM

Alpha Teknova Inc

4.710
-0.100-2.08%

關於 Alpha Teknova Inc 公司

Alpha Teknova, Inc. 是治療、疫苗和分子診斷研究、發現、開發和商業化關鍵試劑的生產商。該公司提供兩條主要業務線,包括實驗室必需品和臨牀解決方案。該公司還提供三種主要產品類型:用於細胞生長和克隆的預灌裝培養基板;用於細胞擴增的液體細胞培養基和補充劑;以及用於樣品處理、再懸浮和純化的分子生物學試劑。該公司在其兩個產品類別中都提供液體細胞培養基和補充劑以及分子生物學試劑;預灌裝培養基板僅在其實驗室必需品類別中提供。其客戶包括製藥和生物技術公司、合同開發和製造組織、體外診斷特許經營商以及開發疫苗和治療並進行基礎研究的學術和政府研究機構。

Alpha Teknova Inc簡介

公司代碼TKNO
公司名稱Alpha Teknova Inc
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream
員工數量173
證券類型Ordinary Share
年結日Jun 25
公司地址2451 Bert Drive
城市HOLLISTER
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編95023
電話18316371100
網址https://www.teknova.com/
公司代碼TKNO
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream

Alpha Teknova Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Alex Herzick
Alex Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%
地區USD
名稱
營收
佔比
United States
9.78M
95.04%
International
510.00K
4.96%
業務
地區
業務USD
名稱
營收
佔比
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%

股東統計

更新時間: 8 分鐘前
更新時間: 8 分鐘前
持股股東
股東類型
持股股東
持股股東
佔比
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
其他
18.01%
持股股東
持股股東
佔比
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
其他
18.01%
股東類型
持股股東
佔比
Private Equity
70.48%
Individual Investor
10.72%
Investment Advisor
6.61%
Investment Advisor/Hedge Fund
4.37%
Hedge Fund
2.90%
Research Firm
1.00%
Pension Fund
0.04%
Bank and Trust
0.03%
其他
3.85%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
142
45.72M
85.43%
-1.12M
2025Q2
134
49.86M
93.29%
-910.00K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Telegraph Hill Partners
37.72M
70.48%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.15%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.58M
2.96%
+424.17K
+36.58%
Jun 30, 2025
Balyasny Asset Management LP
1.00M
1.87%
+163.53K
+19.54%
Jun 30, 2025
Mackowski J Matthew
820.81K
1.53%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.53%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
652.18K
1.22%
+78.74K
+13.73%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
615.90K
1.15%
+480.11K
+353.57%
Jun 30, 2025
Roubaix Capital, LLC
439.94K
0.82%
+439.94K
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
ProShares Nanotechnology ETF
0.78%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
查看更多
ProShares Nanotechnology ETF
佔比0.78%
Invesco Nasdaq Biotechnology ETF
佔比0.03%
ProShares Ultra Nasdaq Biotechnology
佔比0.03%
iShares Biotechnology ETF
佔比0.01%
iShares Micro-Cap ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI